{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:11:36Z","timestamp":1792131096613,"version":"4.4.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:00:00Z","timestamp":1548115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2019.00003","type":"journal-article","created":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T23:56:27Z","timestamp":1548114987000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":80,"title":["Management of Hereditary Spastic Paraplegia: A Systematic Review of the Literature"],"prefix":"10.3389","volume":"10","author":[{"given":"Marta","family":"Bellofatto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"De Michele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniello","family":"Iovino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Filla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo M.","family":"Santorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,1,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/WCO.0000000000000585","article-title":"Hereditary ataxias and paraparesias: clinical and genetic update","volume":"31","author":"Parodi","year":"2018","journal-title":"Curr Opin Neurol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000358801","article-title":"The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies","volume":"42","author":"Ruano","year":"2014","journal-title":"Neuroepidemiology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1055\/s-2008-1040846","article-title":"Hereditary spastic paraplegia: genetic heterogeneity and genotype-phenotype correlation","volume":"19","author":"Fink","year":"1999","journal-title":"Semin Neurol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"CD003980","DOI":"10.1002\/14651858.CD003980.pub2","article-title":"Exercise therapy for multiple sclerosis","volume":"25","author":"Rietberg","year":"2005","journal-title":"Cochrane Database Syst Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.coph.2005.11.003","article-title":"The mechanisms of action of gabapentin and pregabalin","volume":"6","author":"Sills","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/j.1468-1331.2007.01812.x","article-title":"Double-blind crossover trial of gabapentin in SPG4-linked hereditary spastic paraplegia","volume":"14","author":"Scheuer","year":"2007","journal-title":"Eur J Neurol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/135245859700300104","article-title":"The MS impairment scale: a pragmatic approach to the assessment of impairment in patients with multiple sclerosis","volume":"3","author":"Ravnborg","year":"1997","journal-title":"Mult Scler"},{"key":"B8","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1034\/j.1600-0404.2003.00125_18.x","article-title":"SPATAX \u2013 european network for hereditary spinocerebellar degenerative disorders","volume":"107","author":"Tallaksen","year":"2003","journal-title":"Acta Neurol Scand"},{"key":"B9","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1600-0404.1984.tb07802.x","article-title":"The clinical effect of the GABA-agonist, progabide, on spasticity","volume":"69","author":"Mondrup","year":"1984","journal-title":"Acta Neurol Scand"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s00415-015-7707-6","article-title":"Dalfampridine in hereditary spastic paraplegia: a prospective, open study","volume":"262","author":"B\u00e9reau","year":"2015","journal-title":"J Neurol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1212\/01.wnl.0000228242.53336.90","article-title":"The spastic paraplegia rating scale (SPRS): a reliable and valid measure of disease severity","volume":"67","author":"Sch\u00fcle","year":"2006","journal-title":"Neurology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000449375","article-title":"The effects of dalfampridine on hereditary spastic paraparesis","volume":"76","author":"Uygunoglu","year":"2016","journal-title":"Eur Neurol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2340\/16501977-1909","article-title":"Functional effects of botulinum toxin type-A treatment and subsequent stretching of spastic calf muscles: a study in patients with hereditary spastic paraplegia","volume":"47","author":"de","year":"2015","journal-title":"J Rehabil Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/mds.21809","article-title":"Botulinum neurotoxin type A injections reduce spasticity in mild to moderate hereditary spastic paraplegia\u2013report of 19 cases","volume":"30","author":"Hecht","year":"2008","journal-title":"Mov Disord"},{"key":"B15","doi-asserted-by":"publisher","first-page":"758","DOI":"10.2174\/1381612822666151204001830","article-title":"Combined treatment Fkt-botulinum toxin type A (Btx-A) in patients with Strumpell-Lorrain disease","volume":"2016","author":"Riccardo","year":"2016","journal-title":"Curr Pharm Des"},{"key":"B16","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.parkreldis.2004.05.003","article-title":"Levodopa-responsive parkinsonism in hereditary spastic paraplegia with thin corpus callosum","volume":"10","author":"Kang","year":"2004","journal-title":"Parkinsonism Relat Disord"},{"key":"B17","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/mds.23552","article-title":"Novel mutations in SPG11 cause hereditary spastic paraplegia associated with early-onset levodopa-responsive Parkinsonism","volume":"26","author":"Guidubaldi","year":"2011","journal-title":"Mov Disord"},{"key":"B18","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ymgme.2012.05.020","article-title":"Neurotransmitter abnormalities and response to supplementation in SPG11","volume":"107","author":"Vanderver","year":"2012","journal-title":"Mol Genet Metab"},{"key":"B19","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/nrneurol.2015.86","article-title":"Dopa-responsive dystonia\u2013clinical and genetic heterogeneity","volume":"11","author":"Wijemanne","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1007\/s00415-013-7044-6","article-title":"Exome sequencing expands the mutational spectrum of SPG8 in a family with spasticity responsive to L-DOPA treatment","volume":"260","author":"Bettencourt","year":"2013","journal-title":"J Neurol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1007\/s00415-015-7971-5","article-title":"Treatment of SPG5 with cholesterol-lowering drugs","volume":"262","author":"Mignarri","year":"2015","journal-title":"J Neurol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1093\/brain\/awx273","article-title":"Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial","volume":"140","author":"Sch\u00f6ls","year":"2017","journal-title":"Brain"},{"key":"B23","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/brain\/awx297","article-title":"Plasma oxysterols: biomarkers for diagnosis and treatment in spastic paraplegia type 5","volume":"141","author":"Marelli","year":"2018","journal-title":"Brain"},{"key":"B24","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1001\/jamaneurol.2014.116","article-title":"Severe methylenetetrahydrofolate reductase deficiency: clinical clues to a potentially treatable cause of adult-onset hereditary spastic paraplegia","volume":"71","author":"Lossos","year":"2014","journal-title":"JAMA Neurol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/ene.13557","article-title":"Severe 5,10-methylenetetrahydrofolate reductase deficiency: a rare, treatable cause of complicated hereditary spastic paraplegia","volume":"25","author":"Perna","year":"2018","journal-title":"Eur J Neurol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/00002060-199807000-00021","article-title":"Therapeutic electrical stimulation for spasticity: quantitative gait analysis","volume":"77","author":"Pease","year":"1998","journal-title":"Am J Phys Med Rehabil"},{"key":"B27","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3233\/NRE-141196","article-title":"Robotic gait training improves motor skills and quality of life in hereditary spastic paraplegia","volume":"36","author":"Bertolucci","year":"2015","journal-title":"NeuroRehabilitation"},{"key":"B28","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.pmrj.2014.09.008","article-title":"Robot-assisted gait training in a patient with hereditary spastic paraplegia","volume":"7","author":"Seo","year":"2015","journal-title":"PM R"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.gaitpost.2014.01.010","article-title":"The effect of hydrotherapy treatment on gait characteristics of hereditary spastic paraparesis patients","volume":"39","author":"Zhang","year":"2014","journal-title":"Gait Posture"},{"key":"B30","first-page":"110","article-title":"Physical therapy interventions for the patients with hereditary spastic paraparesis. An exploratory case reports","volume":"3","author":"Samuel","year":"2013","journal-title":"Int J Physioth Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.clineuro.2014.05.024","article-title":"Intrathecal baclofen therapy for the symptomatic treatment of hereditary spastic paraplegia","volume":"123","author":"Margetis","year":"2014","journal-title":"Clin Neurol Neurosurg"},{"key":"B32","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0987-7053(00)88866-8","article-title":"Intrathecal baclofen normalizes motor strategy for squatting in familial spastic paraplegia: a case study","volume":"30","author":"Dan","year":"2000","journal-title":"Neurophysiol Clin"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.apmr.2015.01.012","article-title":"Improved gait performance in a patient with hereditary spastic paraplegia after a continuous intrathecal baclofen test infusion and subsequent pump implantation: a case report","volume":"96","author":"Heetla","year":"2015","journal-title":"Arch Phys Med Rehabil"},{"key":"B34","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jocn.2013.04.020","article-title":"Long-term results of selective dorsal rhizotomy for hereditary spastic paraparesis","volume":"21","author":"Kai","year":"2014","journal-title":"J Clin Neurosci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1007\/s00381-016-3122-2","article-title":"Selective dorsal rhizotomy for hereditary spastic paraparesis in children","volume":"32","author":"Sharma","year":"2016","journal-title":"Childs Nerv Syst"},{"key":"B36","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.expneurol.2014.06.011","article-title":"Hereditary spastic paraplegia: clinical-genetic characteristics and evolving molecular mechanisms","volume":"261","author":"Lo","year":"2014","journal-title":"Exp Neurol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1093\/hmg\/ddt644","article-title":"Gene dosage-dependent rescue of HSP neurite defects in SPG4 patients' neurons","volume":"23","author":"Havlicek","year":"2014","journal-title":"Hum Mol Genet"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/hmg\/ddv632","article-title":"Conserved pharmacological rescue of hereditary spastic paraplegia-related phenotypes across model organisms","volume":"25","author":"Julien","year":"2016","journal-title":"Hum Mol Genet"},{"key":"B39","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1172\/JCI26210","article-title":"Intramuscular viral delivery of paraplegin rescues peripheral axonopathy in a model of hereditary spastic paraplegia","volume":"116","author":"Pirozzi","year":"2006","journal-title":"J Clin Invest"},{"key":"B40","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/ana.24633","article-title":"GSK3\u00df-dependent dysregulation of neurodevelopment in SPG11-patient induced pluripotent stem cell model","volume":"79","author":"Mishra","year":"2016","journal-title":"Ann Neurol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.1016\/j.celrep.2018.05.098","article-title":"Inhibition of lysosome membrane recycling causes accumulation of gangliosides that contribute to neurodegeneration","volume":"23","author":"Boutry","year":"2018","journal-title":"Cell Rep"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00003\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T23:56:29Z","timestamp":1548114989000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00003\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,22]]},"references-count":41,"alternative-id":["10.3389\/fneur.2019.00003"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2019.00003","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735022704.793582715","asserted-by":"object"}]},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,22]]},"article-number":"3"}}